This site is intended for healthcare professionals only
LoginRegister
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer DrugsPharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs
Zydus Settles Mirabegron Patent Dispute With Astellas for USD 120 MillionZydus Settles Mirabegron Patent Dispute With Astellas for USD 120 Million
Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo SuccessorSanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor
Lupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India RegionLupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India Region
USFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 ObservationsUSFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 Observations
Akums Secures First UK MHRA Approval for RivaroxabanAkums Secures First UK MHRA Approval for Rivaroxaban
Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTracIndian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac
USFDA Issues 9 Observations to Aurobindos Jedcherla Unit-VII After InspectionUSFDA Issues 9 Observations to Aurobindo's Jedcherla Unit-VII After Inspection
GST Probe at Mankind Pharmas BSV Unit in MumbaiGST Probe at Mankind Pharma's BSV Unit in Mumbai
OneSource Wins Saudi Nod for Generic Ozempic, Partners Hikma for MENA RolloutOneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout
Lupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India RegionLupin Gets 1 Observation for Tarapur Facility After USFDA cGMP Inspection
Over 200 Human and Veterinary Drugs Banned Since 2023, Parliament ToldOver 200 Human and Veterinary Drugs Banned Since 2023, Parliament Told
X